Drug Manufacturers—General Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026 | RAPP Rapport Therapeutics, Inc. - Common Stock | 41.77 USD | +5.16% | +5.40% | +11.95% | +59.49% | 2.00 B USD | ||
| 2067 | MAZE Maze Therapeutics, Inc. - Common Stock | 31.90 USD | -2.86% | +7.34% | +33.75% | -29.16% | 1.77 B USD | ||
| 2767 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.68 USD | -7.93% | -13.10% | +17.88% | -37.36% | 578.20 M USD | ||
| 2958 | CBIO Crescent Biopharma, Inc. - Common Stock | 16.77 USD | -1.53% | -3.68% | -3.51% | +9.61% | 462.38 M USD | ||
| 3049 | UPB Upstream Bio, Inc. - Common Stock | 7.84 USD | -0.25% | +9.19% | +20.06% | -28.66% | 426.65 M USD | ||
| 3290 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.97 USD | -3.17% | -8.72% | +5.65% | -3.79% | 313.91 M USD | ||
| 3552 | QTTB Q32 Bio Inc. - Common Stock | 13.72 USD | +0.73% | +8.12% | +12.55% | +873.05% | 232.64 M USD | ||
| 3713 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 4.40 USD | +0.46% | -4.97% | -1.12% | +79.59% | 177.74 M USD | ||
| 3724 | CNTN Canton Strategic Holdings, Inc. - Common Stock | 2.36 USD | -5.60% | -19.73% | -14.18% | -50.32% | 164.74 M USD | ||
| 3925 | PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.50 USD | -1.19% | -3.10% | +1.63% | -94.44% | 118.36 M USD | ||
| 4043 | PTHS Pelthos Therapeutics Inc. Common Stock | 25.96 USD | +4.42% | -6.85% | -4.03% | +29.03% | 90.23 M USD | ||
| 4097 | SCLX Scilex Holding Company - Common Stock | 9.48 USD | -4.53% | +20.30% | +35.43% | +16.61% | 80.50 M USD | ||
| 4202 | EXOZ eXoZymes Inc. - Common Stock | 7.85 USD | +0.90% | 0.00% | -6.77% | -19.07% | 66.56 M USD | ||
| 4203 | OSTX OS Therapies Incorporated Common Stock | 1.46 USD | -9.32% | -21.51% | -19.78% | +26.96% | 65.03 M USD | ||
| 4339 | IBO Impact BioMedical, Inc. Common Stock | 0.46 USD | +2.22% | -2.13% | -14.81% | +4.55% | 49.60 M USD | ||
| 4352 | DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.39 USD | -3.47% | -12.58% | -7.95% | -53.67% | 46.75 M USD | ||
| 4428 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.92 USD | -3.16% | -1.08% | -8.00% | -17.86% | 38.66 M USD | ||
| 4529 | QCLS Q/C Technologies, Inc. - Common Stock | 3.61 USD | -1.63% | -10.20% | -3.99% | -19.78% | 28.35 M USD | ||
| 4580 | MDCX Medicus Pharma Ltd. - Common Stock | 0.42 USD | -4.55% | +7.69% | +23.53% | -64.41% | 23.80 M USD | ||
| 4801 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.73 USD | -1.35% | -17.05% | -34.23% | -44.27% | 11.02 M USD |
Notícias Drug Manufacturers—General Stocks
Truist eleva preço-alvo da Eli Lilly com força do portfólio de incretinas
AstraZeneca e Daiichi Sankyo perto de acordo de preço para Enhertu no Reino Unido
ARK de Cathie Wood vende AMD e compra SpaceX e X-Energy
Ação da Eli Lilly atinge máxima histórica de US$ 1.238,06
Ação da Johnson & Johnson atinge máxima histórica de US$ 264,98
Semnur Pharmaceuticals assina acordo para investimento de US$ 100 milhões
E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,30%
Gainers Drug Manufacturers—General Stocks
ERNAW Ernexa Therapeutics Inc. - Warrants | 0.1100 | +94.00% |
MDCXW Medicus Pharma Ltd. - Warrant | 0.7100 | +7.58% |
RAPP Rapport Therapeutics, Inc. - Common Stock | 41.77 | +5.16% |
PTHS Pelthos Therapeutics Inc. Common Stock | 25.96 | +4.42% |
PPCB Propanc Biopharma, Inc. - Common Stock | 1.88 | +3.30% |
KAPA Kairos Pharma, Ltd. Common Stock | 0.38 | +2.70% |
IBO Impact BioMedical, Inc. Common Stock | 0.46 | +2.22% |
MANE Veradermics, Incorporated Common Stock | 118.90 | +1.81% |
Losers Drug Manufacturers—General Stocks
VIVS VivoSim Labs, Inc. - Common Stock | 0.79 | -12.22% |
DCOY Decoy Therapeutics Inc. - Common Stock | 6.27 | -10.68% |
OSTX OS Therapies Incorporated Common Stock | 1.46 | -9.32% |
EIKN Eikon Therapeutics, Inc. - Common Stock | 10.68 | -7.93% |
CNTN Canton Strategic Holdings, Inc. - Common Stock | 2.36 | -5.60% |
MDCX Medicus Pharma Ltd. - Common Stock | 0.42 | -4.55% |
SCLX Scilex Holding Company - Common Stock | 9.48 | -4.53% |
DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.39 | -3.47% |